Company Quick10K Filing
Cryo Cell
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 8 $63
10-K 2020-02-28 Annual: 2019-11-30
10-Q 2019-10-15 Quarter: 2019-08-31
10-Q 2019-07-15 Quarter: 2019-05-31
10-Q 2019-04-15 Quarter: 2019-02-28
10-K 2019-02-28 Annual: 2018-11-30
10-Q 2018-10-15 Quarter: 2018-08-31
10-Q 2018-07-16 Quarter: 2018-05-31
10-Q 2018-04-16 Quarter: 2018-02-28
10-K 2018-02-28 Annual: 2017-11-30
10-Q 2017-10-16 Quarter: 2017-08-31
10-Q 2017-07-07 Quarter: 2017-05-31
10-Q 2017-04-13 Quarter: 2017-02-28
10-K 2017-02-28 Annual: 2016-11-30
10-Q 2016-10-17 Quarter: 2016-08-31
10-Q 2016-07-11 Quarter: 2016-05-31
10-Q 2016-04-14 Quarter: 2016-02-29
10-K 2016-02-29 Annual: 2015-11-30
10-Q 2015-10-15 Quarter: 2015-08-31
10-Q 2015-07-15 Quarter: 2015-05-31
10-Q 2015-04-14 Quarter: 2015-02-28
10-K 2015-03-02 Annual: 2014-11-30
10-Q 2014-10-15 Quarter: 2014-08-31
10-Q 2014-07-03 Quarter: 2014-05-31
10-Q 2014-04-14 Quarter: 2014-02-28
10-K 2014-02-28 Annual: 2013-11-30
10-Q 2013-10-15 Quarter: 2013-08-31
10-Q 2013-07-15 Quarter: 2013-05-31
10-Q 2013-04-15 Quarter: 2013-02-28
10-K 2013-02-28 Annual: 2012-11-30
10-Q 2012-10-15 Quarter: 2012-08-31
10-Q 2012-07-16 Quarter: 2012-05-31
10-Q 2012-04-16 Quarter: 2012-02-29
10-K 2012-02-28 Annual: 2011-11-30
10-Q 2011-10-17 Quarter: 2011-08-31
10-Q 2011-07-15 Quarter: 2011-05-31
10-Q 2011-04-14 Quarter: 2011-02-28
10-K 2011-02-28 Annual: 2010-11-30
10-Q 2010-10-15 Quarter: 2010-08-31
10-Q 2010-07-15 Quarter: 2010-05-31
10-Q 2010-04-15 Quarter: 2010-02-28
10-K 2010-03-01 Annual: 2009-11-30
8-K 2020-02-27 Earnings, Exhibits
8-K 2019-11-21 Shareholder Vote
8-K 2019-10-15
8-K 2019-10-08 Other Events
8-K 2019-10-01 Accountant, Exhibits
8-K 2019-07-15 Earnings, Exhibits
8-K 2019-04-15 Earnings, Exhibits
8-K 2019-02-28 Earnings, Exhibits
8-K 2018-12-06 Amend Bylaw, Exhibits
8-K 2018-10-15 Earnings, Exhibits
8-K 2018-08-13 Leave Agreement, Officers, Shareholder Vote, Exhibits
8-K 2018-07-16 Earnings, Exhibits
8-K 2018-06-11 Enter Agreement, M&A, Sale of Shares, Exhibits
8-K 2018-05-29 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-05-21 Officers, Exhibits
8-K 2018-03-09 Officers, Other Events, Exhibits
8-K 2018-02-28 Earnings, Exhibits
8-K 2018-02-28 Earnings, Exhibits

Cryo Cell Financials

CCEL Metrics, Comps, Filings

Annual | Quarterly

Business

Cryo-Cell International, Inc. (the "Company" or "Cryo-Cell") is a Delaware corporation that was incorporated in 1989. The Company is organized in three reportable segments, cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use, the manufacture of PrepaCyte® CB Processing System ("PrepaCyte CB") units, the processing technology used to process umbilical cord blood stem cells and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company, in combination with its global affiliates, currently stores nearly 500,000 cord blood and cord tissue specimens worldwide for the exclusive benefit of newborn babies and possibly other members of their families. Founded in 1989, the Company was the world's first private cord blood bank to separate and store stem cells in 1992. All aspects of its U.S.-based business operations, including the processing and storage of specimens, are handled from its headquarters facility in Oldsmar, Florida. The specimens are stored in commercially available cryogenic storage units at this technologically and operationally advanced facility.

In recent years, utilizing its infrastructure, experience and resources derived from its umbilical cord blood stem cell business, the Company has expanded its research and development activities to develop technologies related to stem cells harvested from sources beyond umbilical cord blood stem cells. During fiscal 2011, the Company introduced the advanced new cord tissue service, which stores a section of the umbilical cord tissue. The Company offers the cord tissue service in combination with the umbilical cord blood service. This service is growing; however, the umbilical cord blood service continues to be the Company's main focus.

Cord Blood Stem Cell Processing and Storage Business


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Terra Tech (TRTC) 66,554 55% -5.5 -23% 144,218 34,078 31,730 17,497 -33,504 -15,277 83,382
India Globalization Capital (IGC) 66,379 2% -10.2 -15% 33,505 1,085 5,287 131 -4,963 -4,898 49,825
MRI Interventions (MRIC) 65,694 66% -14.0 -41% 13,270 6,362 9,162 6,003 -5,417 -4,365 61,233
Yatra (TRTL) 65,640 -20.6 -3% 99,561 6,580 0 0 -3,178 -3,178 65,500
OLB Group (OLBG) 65,533 0% -2,700.3 -8% 11,625 14,094 5,173 0 -880 -28 74,978
Vegalab (VEGL) 65,417 14% -32.6 -22% 10,374 4,714 11,635 1,671 -2,270 -2,012 65,545
Lightwave Logic (LWLG) 64,891 -11.0 -94% 6,815 1,991 0 0 -6,396 -5,722 62,687
Radisys (RSYS) 64,574 27% -97.1 -33% 57,835 65,385 109,918 29,205 -19,359 -578 56,127
Peoples Financial (PFBX) 64,261 8.3 0% 622,422 529,553 0 0 351 3,660 30,207
EPHS Holdings (STNN) 64,223 -239.0 -10% 3,000 1,797 0 0 -293 -274 65,444
Electrum Special Acquisition (ELECU) 64,124 -356.8 -0% 128,485 11,837 0 0 -180 -180 64,096
Prime Meridian Holding (PMHG) 63,003 0% -1.6 1% 450,727 397,731 68 0 3,917 5,682 -9,039
Summer Energy (SUME) 62,976 9% -11.0 -16% 53,240 40,697 153,959 13,894 -8,537 -6,301 69,514
Cryo Cell (CCEL) 62,661 68% 14.7 4% 40,889 48,983 32,088 21,832 1,465 4,588 67,644
I-On Communications (ALES) 62,354 47% 63.5 8% 8,551 2,134 5,500 2,598 675 950 60,373
Kaanapali Land (KANP) 62,158 0% -10.6 -2% 107,830 24,720 4,765 9 -2,327 -3,222 34,091
Santa Fe Gold (SFEG) 61,079 6.6 729% 1,228 15,246 0 0 8,947 9,931 65,322
iWeb (IWBB) 60,297 86% -81.5 -64% 1,157 222 14 12 -737 -735 59,829
Galaxy Gaming (GLXZ) 59,468 99% 16.9 12% 22,928 52,519 20,410 20,197 2,793 5,922 99,859
China Health Industries (CHHE) 58,986 76% 4.3 7% 45,755 8,572 9,275 7,037 3,307 5,434 23,478

Balance Sheet ($'000)2011-11-302012-11-302013-11-302014-11-302015-11-302016-11-302017-11-302018-11-30
Cash6,3052,6773,9253,2794,1523,5006,2796,040
Accounts Receivable3,0593,4023,3364,0723,0584,0535,1265,867
Inventory47636131516,036
PP&E1,5401,2816,7759538799798821,493
Assets19,46712,33111,50110,21019,49819,53823,91042,390
Accounts Payable1,0051,2101,1959931,3291,4851,9291,262
Long-Term Debt2,8502,3002,3002,3008697,8205,2959,844
Liabilities21,92721,32820,76920,93624,46234,95336,41351,298
Stockholders' Equity-2,460-8,998-9,268-10,727-4,964-15,414-12,503-8,908
Income Statement ($'000)2011-11-302012-11-302013-11-302014-11-302015-11-302016-11-302017-11-302018-11-30
Revenue16,55516,62817,69818,65519,62021,77223,93929,218
Cost of Revenue4,3994,8885,3225,6325,6315,7756,7248,540
Gross Profit12,15511,74012,37513,02313,98915,99717,21520,679
R&D184110366446534192
SG&A12,41314,42611,36612,25212,38914,72313,48115,633
Tax1721,888170124-7,157-1,1591,3094,473
Net Income-2,096-6,308275548,106-1,3212,315-855
Cash Flow ($'000)2011-11-302012-11-302013-11-302014-11-302015-11-302016-11-302017-11-302018-11-30
Cash Operating8193618221,5554,8514,9885,7185,333
Cash Investing-2,9649621,149391-719-37093-11,282
Cash Financing81-4,951-724-2,592-3,259-5,271-3,0325,710